Maine Medicine Weekly Update - Maine Medicine Weekly Update: 12/24/2021  (Plain Text Version)

Return to Graphical Version

 

In this issue:
HAPPY HOLIDAYS FROM THE MMA
•  Enjoy The Holidays, Our Weekly Newsletter & Thank You For All You Do
COVID-19 CORNER
•  FDA Updates: Pfizer & Merck Oral Antivirals Authorized; Omicron & Monoclonal Antibodies
•  Maine CDC Updates & Guidance
•  Reminder: Everyone Ages 16 and Older Can Get a Booster Shot
•  US CDC Reduces Time for Health Care Workers to Isolate & Updates School Guidelines
•  English Study: Booster Shots Protect Against Omicron for About 10 Weeks
•  Patients Vaccinated for COVID-19 Have Shorter Hospital Stays Than Unvaccinated Patients
•  JAMA Internal Medicine - Illness Severity With SARS-CoV-2 Infection, Delta vs Beta Variant
•  US Supreme Court to Take Up Federal COVID-19 Vaccine Rules
WHAT'S NOT COVID RELATED
•  CDC: Physicians Should Discuss Meds to Reduce HIV Risk
•  HHS: $48 Million Available to Increase the Public Health Workforce in Rural and Tribal Communities
•  MaineCare: Payment Cycle Reminder: Christmas and New Year's Day Holidays
IN THE NEWS
•  Medicine in the Media
•  Walgreens Pharmacy Hours Change: Call Ahead Before Picking Up Your Medication
MAINE MEDICAL ASSOCIATION JOB OPPORTUNITY
•  Maine Medical Education Trust (MMET) CME Program Coordinator
HEALTH COVERAGE
•  Open Enrollment For 2022 Individual Health Plans
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  Governorís Opioid Response Seminar Webinar Series Continues (Jan 7)
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Psychiatric Nurse Practitioner (PNP) - Greater Portland Health
•  Transformational OB/GYN or Maternal Fetal Medicine Physician leader

 

JAMA Internal Medicine - Illness Severity With SARS-CoV-2 Infection, Delta vs Beta Variant

Question:  Do patients infected with the SARS-CoV-2 Delta variant experience more severe disease outcomes compared with those infected with the Beta variant?

Findings:  In this cohort study of 1427 persons infected with the Delta variant and 5353 persons infected with the Beta variant in Qatar, among 451 propensity score–matched pairs identified, persons infected with the Delta variant were more likely to be hospitalized (27.3% vs 20.0%) or to experience more severe disease outcomes. Infection with the Delta variant was independently associated with higher odds of experiencing any adverse outcome, and vaccination was associated with significantly reduced odds of severe disease outcomes.

Meaning:  In this cohort study, infection with the Delta variant was more severe than infection with the Beta variant in persons in Qatar, although vaccination was highly protective against severe outcomes for both variants.

Question:  Do patients infected with the SARS-CoV-2 Delta variant experience more severe disease outcomes compared with those infected with the Beta variant?

Findings:  In this cohort study of 1427 persons infected with the Delta variant and 5353 persons infected with the Beta variant in Qatar, among 451 propensity score–matched pairs identified, persons infected with the Delta variant were more likely to be hospitalized (27.3% vs 20.0%) or to experience more severe disease outcomes. Infection with the Delta variant was independently associated with higher odds of experiencing any adverse outcome, and vaccination was associated with significantly reduced odds of severe disease outcomes.

Meaning:  In this cohort study, infection with the Delta variant was more severe than infection with the Beta variant in persons in Qatar, although vaccination was highly protective against severe outcomes for both variants.

Online: Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar